Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeynes, B. J.
Right arrow Articles by Warren, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeynes, B. J.
Right arrow Articles by Warren, B. A.

Stroke, Vol 13, 312-318, Copyright © 1982 by American Heart Association


ARTICLES

Cerebral atheroembolism. An animal model

BJ Jeynes and BA Warren

Human atheromatous material was injected into the cerebral vasculature of anaesthetized rabbits via the left common carotid artery. The lethality of varying dosages was determined and the distribution and general character of occlusive vascular lesions which developed were analyzed by light and transmission electron microscopy. It was found that a dose exceeding 55 mg of the atheromatous material (125 mg/ml saline) was lethal in New Zealand white male rabbits weighing between 3 and 5 kg. In nonsurviving animals, parts of the Circle of Willis and usually one or more of its major tributaries were occluded. Some surviving animals exhibited signs of neurologic deficit evidenced by motor dysfunction. Occlusive vascular lesions found in surviving animals were predominantly localized in ipsilateral cortical and subcortical vessels within the distribution territory of the middle cerebral artery. The character of occlusive lesions showed strong evidence of thrombosis. These results demonstrated that this experimental system may be useful as a model for the study of blood- atheroembolic vascular reactions, cerebral infarction development and the testing of agents potentially prophylactic against the development or stabilization of occlusive lesions.